There are many similarities between embryonic development and tumorigenesis, and gene expression profiles show that certain correlations exist between the gene signature during development and the clinical phenotypes of different cancers. Our group previously reported the gene expression profiles of human lung development, and the expression of one group of proliferation-related genes (PTN1 genes) steadily decreased during lung development. Here, we examined the prognostic value of PTN1 genes in 5 independent lung adenocarcinoma (ADC) and 5 lung independent squamous cell carcinoma (SCC) microarray datasets and found that the expression levels of PTN1 genes were associated with survival in lung ADC but not lung SCC.
There are many similarities between embryonic development and tumorigenesis, and gene expression profiles show that certain correlations exist between the gene signature during development and the clinical phenotypes of different cancers. Our group previously reported the gene expression profiles of human lung development, and the expression of one group of proliferation-related genes (PTN1 genes) steadily decreased during lung development. Here, we examined the prognostic value of PTN1 genes in 5 independent lung adenocarcinoma (ADC) and 5 lung independent squamous cell carcinoma (SCC) microarray datasets and found that the expression levels of PTN1 genes were associated with survival in lung ADC but not lung SCC.
All of the lung ADC datasets contained a set of highly correlated genes from PTN1 genes, but the lung SCC datasets had no similar set of genes. We identified 63 unique core genes from the PTN1 genes in the 5 lung ADC datasets: 17 of these core genes appeared in at least 4 of the lung ADC datasets, and the 17 corresponding proteins clearly interacted more strongly with each other in lung ADC than in lung SCC. Moreover, 16 of the 17 core genes play major roles in the G 2 /M phase of the cell cycle. These data indicate that proliferation-related genes in lung development have a significant prognostic value for lung ADC; the synergistic effects of the 17 core genes play an important role in lung ADC prognosis. These genes may have significant clinical implications for the treatment and prognosis of lung ADC.
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| INTRODUCTION
The intimate connection between tumorigenesis and developmental processes has been studied for many years. There are clear analogies between cancer and development. Morphologically, cancerous tissues appear as undifferentiated or poorly differentiated, with some tumor types even exhibiting embryonic tissue. 1 Behaviorally, the ability of tumor cells to grow, to infiltrate, and to suppress the immune system is similar to that of embryonic cells. 
| RNA extraction and gene expression microarray
Total RNA from the paracancerous tissues was isolated with TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and purified using an RNeasy kit (Qiagen, Germantown, MD, USA). RNA was then quantified using an ND-1000UV-VIS Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA), and RNA integrity was determined using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). All RNA samples used in this study showed optical density 260/280 ratios >1.9 and RNA integrity >6. Paracancerous tissue samples were analyzed using an Agilent Whole Human Genome Microarray 4 9 44K (G4112F). All sample labeling, hybridization, washing, and scanning steps were carried out following the manufacturer's specifications. The slides were scanned with an Agilent Microarray Scanner System (G2505B), and the fluorescence intensities were extracted and preprocessed using Agilent Feature Extraction Software version 9.1. Data extraction and annotation were carried out using GeneSpring GX version 12.6.1 (Agilent). The raw data were normalized by the median scale method using the R package "limma" (www.r-projec t.org). Screening probes represented the same gene, and only the probe showing the greatest mean intensity was retained. All raw microarray data and normalized data are publicly available on the GEO website (accession no. GSE101420). (Table S3) and their corresponding clinical information were collected from existing publications for validation. Our previous study on lung development included 4 developmental stages and 69 lung ADC samples, and their gene expression profile data are available from the GEO database (GSE43767) 12 ; these 69 lung ADC samples were named "ADC_Ours" in this study. Clinical information of ADC_Ours is provided in Table S4 .
The median follow-up period was 3.34 years. The raw data were normalized using the same method used for the paracancerous group, except GSE8894. Because the raw data for GSE8894 were not provided, the GC robust multi-array average processed data were downloaded and analyzed directly.
| Statistical analysis
The gene set enrichment analysis was carried out using DAVID tools (http://david.abcc.ncifcrf.gov/). All statistical analyses in this study were undertaken using R software. In detail, differential gene expression analyses were carried out using an unpaired Student's t-test (R package "stats"). Prognosis was evaluated by the log-rank test (R package "survival"). Correlations between genes were evaluated using the correlation test (R package "stats"). Significant differences in the correlation coefficients between lung ADC and SCC were evaluated using a 2-way ANOVA (R package "stats"). Graphical visualization of the protein-protein interaction (PPI) networks were generated using Cytoscape software. showed a significant difference in prognosis between the low-risk and high-risk groups in all 4 independent sets of lung ADC (ADC_GSE13213, n = 117, P = .012; ADC_GSE8894, n = 62, P = .0023; ADC_NCI, n = 282, P = .000 18; and ADC_PNAS, n = 190, P = .024). In contrast, no significant difference in prognosis was noted between the low-risk and high-risk groups in 4 independent sets of lung SCC (SCC_GSE19188, n = 27, P = .099; SCC_GSE8894, n = 76, P = .6; SCC_GSE4573, n = 130, P = .99; and SCC_GSE14814, n = 52, P = .93) ( Figure S1 ).
| Group of highly correlated genes exists in lung ADC
Because PTN1 genes share similar biological functions, mainly related to cell proliferation ( Figure 1C) , there might be a correlation among the PTN1 genes. To explore correlations among PTN1 genes, correlation tests were carried out on ADC_Ours, SCC_Ours and 4 independent sets each of lung ADC and SCC microarray data.
Because the test statistics (t-value) of the correlation tests followed a Student's t-distribution, we used test statistics to observe the correlations among PTN1 genes. To better display the correlations, we determined the 90th percentile of the test statistics for each gene in relation to the other genes and then used the 90th percentile as an index to re-rank the genes, finally generating heat maps to illustrate the correlations. As shown in Figure 3 , a group of highly related genes exists in the ADC_Ours dataset (the red region), but the F I G U R E 1 Expression features and functional annotations of proliferation-related genes involved in lung development (PTN1 genes). A, Expression levels of PTN1 genes are presented as box diagrams. The sample types are plotted on the x-axis, and the normalized average gene expression level in every sample type is plotted on the y-axis. EarlyL, early embryonic lung at 6-8 postovulatory weeks (PWs); MatureL, adult cancer-free peripheral lung tissue subject to surgery for benign lung diseases; MiddleL, middle embryonic lung at 16-4 PWs; PC, paracancerous; WholeE, whole embryos at 3- (>90th percentile) of the genes that were re-ranked, as described earlier, and named them "core genes"; these genes represent the majority of genes in the red regions. 
Characteristics of core genes in lung adenocarcinoma (ADC_Ours) and squamous cell carcinoma (SCC_Ours) datasets, containing gene expression data from 69 lung ADC samples and 69 lung SCC samples, respectively. A, The Venn diagram displays the overlap of the core genes of 5 independent lung ADC datasets. Each dataset is colored, and the numbers indicate the number of overlapping genes. B, The difference in the correlation coefficients of 17 core genes between the lung ADC and SCC datasets. The correlation coefficients of the 17 core genes in the lung ADC datasets are higher than those in the lung SCC datasets; 2-way ANOVA was used to determine the significant difference (P < .0001). (C, D) Protein-protein interaction networks of associated proteins encoded by the 17 core genes in the lung ADC_Ours and SCC_Ours datasets. The nodes represent core genes, and the edges represent correlation coefficients, the colors of the edges represent the r value from the correlation test. Red edges represent an r value ≥.7 and <1; blue edges represent an r value ≥.4 and <.7; black edges represent an r value >0 and <.4. The 17 proteins clearly interact more strongly with each other in the lung ADC_Ours dataset (C) than in the lung SCC_Ours dataset (D)
core genes of the 5 lung ADC datasets, we obtained 63 unique core genes (Table S5) . Of these core genes, 7 (TPX2, SPAG5, CCNA2, KIF14, TTK, RFC4, and BUB1B) belonged to all 5 datasets and 10 (CDCA8, FANCI, NCAPH, PRC1, NEK2, KIF20A, KIF15, KIF4A, FAM64A, and BIRC5) belonged to 4 datasets (ADC_Ours, ADC_GSE13213, ADC_GSE8894, and ADC_NCI) ( Figure 4A ).
Because the ADC_PNAS dataset was obtained from an earlier type of microarray (Table S2) , which contained fewer genes compared with the microarrays used for the other 4 lung ADC datasets, these 10 genes and the 7 genes common to all 5 datasets were further studied by us. Figure 4B shows that the correlation coefficients of these 17 core genes in the lung ADC datasets were higher than those in the lung SCC datasets, and a 2-way ANOVA revealed a significant difference (P < .0001). Using the lung ADC_Ours and lung
SCC_Ours datasets as representatives, we constructed PPI networks using Cytoscape to show how these 17 genes were related to each other in terms of interactions between their associated proteins. In 
| DISCUSSION
Genome-wide transcriptional profiling has identified gene expression signatures that are similar in organogenesis and tumors. 4, 22, 23 Signaling, transcriptional, and metabolic pathways that are shared between fetal development and malignant tumors are reflected in the reactivation of embryonic genes in tumors. [24] [25] [26] [27] As the embryonic lung gradually matures, the expression of PTN1 genes, which are mainly related to cell proliferation, steadily decreases, and these proliferation-related genes are increased in lung cancer to adapt to the continuous division and proliferation of tumor cells. These trends in gene expression changes are consistent with previous theories that embryonic genes are reactivated in malignant tumors.
Several studies have determined that cell proliferation-related genes contribute to prognostic predictive ability, [28] [29] [30] and developmental gene signatures can be used to predict outcomes. 4, 5, 31 It has been reported that an ESC gene expression signature was associated with the prognosis of lung ADC patients but was not associated with SCC; the study authors postulated that this occurred because the lung ADC samples expressed a higher percentage of survival-related genes in the ESC gene set than did the SCC samples, suggesting that lung ADC has a molecular signature that is similar to the ESC profile. 11 However, this explanation is inadequate. The PTN1 genes are proliferation-related genes expressed during lung development.
In this study, we discovered that PTN1 genes could predict the prognosis in all 5 lung ADC datasets but had no prognostic value for any of the 5 lung SCC datasets. In addition, we provided evidence for this difference from the standpoint of correlated genes. In this study, we used a correlation test to reveal a set of correlated genes in all 5 lung ADC datasets, but none of the lung SCC datasets expressed such genes. This finding might explain why the PTN1 genes were associated with the overall survival of patients with lung ADC but not with patients with lung SCC. The synergistic effects of these correlated genes might play an important role in lung ADC, whereas the synergistic effects of these genes are destroyed in lung SCC, resulting in a loss of ability to predict prognosis. Other mechanisms might play an important role in causing the different prognostic value of the PTN1 genes for lung ADC and SCC.
Based on the histopathological appearance and gene expression signatures, it is speculated that lung ADC and SCC arise from distinct cells. It is generally accepted that lung ADC originates mainly from alveolar epithelial cells, such as the type II pneumocyte lineage, by progressing through a series of stages from atypical adenomatous hyperplasia to adenoma to ADC. 32, 33 However, it was reported that the histopathology and gene expression patterns of lung SCC resembled tracheal basal cell progenitors, and lung SCC expressed the basal cell markers p63 and CK5/14. Therefore, it is speculated that lung SCC is possibly derived from basal cells [33] [34] [35] [36] and has a stepwise progression from normal bronchial epithelium to squamous metaplasia, dysplasia, and SCC. 37 Lung ADC and SCC undergo distinct developmental processes. In particular, lung SCC progresses through a particular step in the form of squamous metaplasia. It may be that lung ADC has molecular characteristics similar to the PTN1 genes, and this similarity is maintained during the progression of lung ADC; however, lung SCC might develop without such molecular characteristics due to its different cellular origins and developmental stages. It is our hope that this study will provide a new clue for investigating the developmental and clinical differences between human lung ADC and SCC. 
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